Literature DB >> 7298853

Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets.

M A Blajchman, A F Senyi, J Hirsh, E Genton, J N George.   

Abstract

Although in vitro studies have demonstrated functional differences between young and old platelets, in vivo differences have not been precisely established. Therefore the in vivo hemostatic function of young and old platelets and the survival time have been examined in rabbits. The hemostatic function was measured by performing serial ear bleeding times in irradiation-induced thrombocytopenic rabbits. After irradiation with 930 rad the platelet count gradually diminished reaching a nadir ( approximately 20 x 10(3)/mul) at 10 d. The platelets present in the circulation, 7-10 d after irradiation, were considered old platelets, and the platelets present after recovery, 11-14 d postirradiation, young platelets. The measurement of platelet size was consistent with the hypothesis that platelets become smaller with age: the mean size was 3.84 mum(3) for old platelets and 5.86 mum(3) for young platelets. Regression analysis of the relationship between the bleeding time and the platelet count in 18 rabbits showed a significantly different slope for rabbits with predominantly old platelets compared with rabbits with predominantly young platelets (P < 0.001). Young platelets were more effective giving much shorter bleeding times than old platelets at comparable platelet counts. Survival times of young and old platelets were measured using platelets harvested on day 8 postirradiation (old platelets) and day 12 postirradiation (young platelets) that were labeled and then reinjected into normal recipient animals. The mean platelet survival time, calculated by gamma function, of old platelets was 28.8 h; of young platelets, 87.4 h; and of normally circulating heterogeneous platelets, (normal platelets) 53.0 h. Notably, the survival of old platelets was found to be exponential, and of young platelets, linear. Analysis of the membrane glycoproteins in young, old and normal platelets indicated that there was no qualitative difference amongst the young, normal, and old platelets. The relative relationship among all the glycoprotein peaks was equal and the only changes observed were quantitative, with young platelets having significantly more membrane glycoprotein per cell than old platelets and normal platelets. Normal platelets had intermediate concentrations of each glycoprotein. These results demonstrate that young platelets are hemostatically more effective in vivo than old platelets. The data are compatible with the hypothesis that platelets age in the circulation by losing membrane fragments and then after becoming senescent, are removed from the circulation by a random process.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298853      PMCID: PMC370924          DOI: 10.1172/jci110375

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Hetrogeneity of human platelets. 3. Glycogen metabolism in platelets of different sizes.

Authors:  S Karpatkin; A Charmatz
Journal:  Br J Haematol       Date:  1970-08       Impact factor: 6.998

2.  Protein synthesis in aging blood platelets.

Authors:  M Steiner; M Baldini
Journal:  Blood       Date:  1969-04       Impact factor: 22.113

3.  The bleeding time as a screening test for evaluation of platelet function.

Authors:  L A Harker; S J Slichter
Journal:  N Engl J Med       Date:  1972-07-27       Impact factor: 91.245

4.  Lipid peroxidation in aging platelets.

Authors:  M Okuma; M Steiner; M Baldini
Journal:  Blood       Date:  1969-11       Impact factor: 22.113

5.  Kinetic studies with 51-chromium-labeled platelet cohorts in rats.

Authors:  A D Ginsburg; R H Aster
Journal:  J Lab Clin Med       Date:  1969-07

6.  Evidence that the spleen retains the youngest and hemostatically most effective platelets.

Authors:  N R Shulman; S P Watkins; S B Itscoitz; A B Students
Journal:  Trans Assoc Am Physicians       Date:  1968

7.  The estimation of blood platelet survival. II. The multiple hit model.

Authors:  E A Murphy; M E Francis
Journal:  Thromb Diath Haemorrh       Date:  1971

8.  The effect of platelet age on platelet adherence to collagen.

Authors:  J Hirsh; M F Glynn; J F Mustard
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

9.  Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets.

Authors:  S Karpatkin
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

10.  Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets.

Authors:  S Karpatkin
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more
  9 in total

1.  Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Michael F Murphy; Alan Tinmouth
Journal:  Cochrane Database Syst Rev       Date:  2014

2.  Increases in platelet and red cell counts, blood viscosity, and arterial pressure during mild surface cooling: factors in mortality from coronary and cerebral thrombosis in winter.

Authors:  W R Keatinge; S R Coleshaw; F Cotter; M Mattock; M Murphy; R Chelliah
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-24

3.  Proteome and functional decline as platelets age in the circulation.

Authors:  Harriet E Allan; Melissa A Hayman; Simone Marcone; Melissa V Chan; Matthew L Edin; Tania Maffucci; Abhishek Joshi; Laura Menke; Marilena Crescente; Manuel Mayr; Darryl C Zeldin; Paul C Armstrong; Timothy D Warner
Journal:  J Thromb Haemost       Date:  2021-08-27       Impact factor: 16.036

Review 4.  Intravenous hemostats: challenges in translation to patients.

Authors:  Margaret Lashof-Sullivan; Andrew Shoffstall; Erin Lavik
Journal:  Nanoscale       Date:  2013-10-02       Impact factor: 7.790

5.  Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocol.

Authors:  Lise J Estcourt; Simon J Stanworth; Dave Collett; Mike F Murphy
Journal:  BMJ Open       Date:  2014-02-07       Impact factor: 2.692

Review 6.  Fruitflow®: the first European Food Safety Authority-approved natural cardio-protective functional ingredient.

Authors:  Niamh O'Kennedy; Daniel Raederstorff; Asim K Duttaroy
Journal:  Eur J Nutr       Date:  2016-07-07       Impact factor: 5.614

Review 7.  Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Patricia Blanco; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-10-27

Review 8.  Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood.

Authors:  Miriam Erlacher; Brigitte Strahm
Journal:  Front Pediatr       Date:  2015-07-13       Impact factor: 3.418

Review 9.  Toward the Relevance of Platelet Subpopulations for Transfusion Medicine.

Authors:  Stefan Handtke; Leif Steil; Andreas Greinacher; Thomas Thiele
Journal:  Front Med (Lausanne)       Date:  2018-02-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.